ANNUAL REPORT 20141 OVERVIEW 2014 Highlights

Total Page:16

File Type:pdf, Size:1020Kb

ANNUAL REPORT 20141 OVERVIEW 2014 Highlights PLAZA CENTERS 2014 ANNUAL REPORT PLAZA CENTERS Who we are We are a leading Central and Eastern European property developer focusing on western-style Contents shopping and entertainment centers, with a Who we are diversifi ed platform of operations in India. Overview Who we are . 1 2014 highlights . 2 The Plaza Centers Group is a leading emerging markets developer Market in the United States. (For more information visit Our strategy . 4 of shopping and entertainment centers, focusing on developing new www.elbitimaging.com.) Feature developments . 6 centers and, where there is signifi cant redevelopment potential, Debt restructuring . 8 Competitive strengths . 10 redeveloping existing centers, in both capital cities and important The Group has been present in real estate development in emerging Our markets . 14 regional centers. The Group has been present in the Central and markets for more than 19 years, initially pursuing shopping Our portfolio at a glance . 15 Eastern Europe region (“CEE”) since 1996 and was the fi rst to and entertainment center development projects in Hungary and Development focus . 16 develop western-style shopping and entertainment centers in Hungary. subsequently expanding into Poland, the Czech Republic, Romania, Current portfolio . 18 The Group has pioneered this concept throughout the CEE whilst Latvia, Greece, Serbia, Bulgaria and India. To date, the Group has building a strong track record of successfully developing, letting and developed and let 33 shopping and entertainment centers in the Business review selling shopping and entertainment centers. Since 2006, the Group CEE region and India, of which 27 were sold with an aggregate President and Chief Executive Offi cer’s statement . 28 has extended its area of operations beyond the CEE into India. In gross value of circa €1.2 billion. 21 of these centers were acquired Operational review . 31 2012, Plaza identifi ed, with its joint venture partners, a window of by Klepierre, a leading player in the continental European shopping Financial review . 36 opportunity for investment in the US as a result of the dislocation center property market, which owns circa 180 shopping centers in Valuation summary by Cushman and Wakefi eld . 38 of the property market, specifi cally within the retail sector. In 2010, 16 countries in continental Europe, with a property portfolio value taking advantage of its qualities and experience in identifying of €21 billion as of year end 2014. Four additional shopping and Management and governance opportunities, managing and exiting assets, gained over the years, entertainment centers were sold to the Dawnay Day Group, one Management structure . 39 the Group completed another signifi cant sale of 49 US-based assets, of the UK’s leading institutional property investors at that time. Board of Directors and Senior management . 40 mainly to a joint venture between Blackstone Real Estate and DDR One shopping center was sold in 2007 to Active Asset Investment Directors’ report . 42 Corp. in a transaction valued at US$1.47 billion, which refl ects a Management (“AAIM”), a UK commercial property investment group. Corporate governance . 46 ROE for the Group of nearly 50% in a period of little over 18 months. The transaction had a completion value totaling approximately Risk management . 53 €387 million, representing circa 20% of all real estate transactions Remuneration report . 62 During 2014, Plaza successfully completed the restructuring process completed in Hungary in 2007. Kragujevac Plaza was sold in 2014 Statement of the directors . 65 midway through the year, with resounding support from its creditors. to New Europe Property Investments plc (“NEPI”), a publicly traded Financial statements This was followed by the completion of a successful rights offering, commercial property investor and developer in Eastern Europe, which provided Plaza with a €20 million capital injection and marked holding 26 income producing assets. Independent auditors’ report . 66 an important fi nal step in the restructuring process. A third listing Consolidated statement of fi nancial position . 67 Consolidated statement of profi t or loss . 68 on the Tel Aviv Stock Exchange and the recent upgrade in Plaza’s Consolidated statement of comprehensive income . 69 credit rating from the Israeli division of Standard & Poor’s (from Consolidated statement of changes in equity . 70 “D” to “BBB-”, on a local Israeli scale, with a stable outlook), have Consolidated statement of cash fl ows . 71 further underlined the achievements of the year and strengthens the Notes to the consolidated fi nancial statements . 73 Company’s position. This annual report is not intended for Dutch statutory fi ling purposes. Additional information Throughout 2014, Plaza continued operational improvement The Company is required to fi le an annual Company’s offi ces . 138 and portfolio repositioning. These are clearly expressed by report containing consolidated and Company Advisors . 139 signifi cant headway made with the disposal of Kragujevac Plaza fi nancial statements prepared in accordance for €38.6 million and successful disposal of non-core sites in with the Netherlands Civil Code – such a report Romania (Targu Mures and Hunedoara) for €4.7 million in line with will be submitted in due course to the Dutch the Company’s strategy to pay down debt and shed the portfolio of Serbia authorities and will be available for non-core assets. At the same time Plaza improved occupancy and shareholders’ inspection at the Company’s turnover were recorded across the Company’s existing shopping and offi ces in Amsterdam. entertainment centers in CEE, with the overall portfolio occupancy Since 1 November 2006, Plaza Centers N.V.’s shares have been level increasing to 94% as of year-end, refl ecting successful asset traded on the main board of the London Stock Exchange under the management initiatives at Torun Plaza, Riga Plaza, Suwalki Plaza ticker “PLAZ”. From 19 October 2007, Plaza Centers N.V.’s shares and Zgorzelec Plaza. During 2014 NOI increased by 3.5%. are also traded on the main list of the Warsaw Stock Exchange under the ticker “PLZ”, making it the fi rst property company to achieve The Company is an indirect subsidiary of Elbit Imaging Ltd. (“EI”), an this dual listing, and as of 27 November 2014, Plaza Centers N.V.’s Israeli public company whose shares are registered for trade on the shares are also traded on the Tel Aviv Stock Exchange under the Tel Aviv Stock Exchange in Israel and on the NASDAQ Global Select ticker “PLAZ”. PLAZA CENTERS N.V. ANNUAL REPORT 20141 OVERVIEW 2014 highlights Signifi cant headway in the repositioning of portfolio, disposing of a number of non-core assets and successful completion of the restructuring process. 2014 highlights Asset and operational highlights Total assets Net Asset Value (NAV) • Net Asset Value decreased by 44% to €153 million (31 December 2013: €274 million) primarily as a result of the • During the period, Plaza made signifi cant headway in the 2014: €466 million 2014: €153 million impairment of assets, mainly in Romania, Greece and India. repositioning of its portfolio, disposing of a number of - Net Asset Value per share of £0.17 (31 December 2013: £0.79), 2013: €586 million €m 1500 2013: €274 million €m 1200 non-core assets: a decline of 78%, attributable to dilution (increase in the - In the fourth quarter of 2014, 18 months ahead of schedule, 1000 number of shares by 130%) and the abovementioned 1200 Plaza successfully completed the disposal of Kragujevac Plaza impairments. in Serbia for €38.6 million, in line with the asset’s last reported 800 900 book value. Following the repayment of related bank debt of • Losses in the period of €120 million (31 December 2013: 600 c. €28.2 million, 75% of the net cash proceeds (c. €12.4 million, loss of €218 million), stemming from a non-cash €89 million 600 including the released restricted cash deposit of c. €2 million) 400 impairment of trading properties and equity accounted investees were distributed to the Company’s bondholders as an early (31 December 2013: €186 million of impairments), and an overall 300 repayment of the bonds, in line with the Company’s stated 200 net fi nance cost of €36 million (2013: €39 million). restructuring plan. - Basic and diluted loss per share of €0.39 (31 December 2013: 0 0 - Successful disposals of non-core sites in Romania, at Targu 2007 2008 2009 2010 2011 2012 2013 2014 2007 2008 2009 2010 2011 2012 2013 2014 loss per share of €0.73). Mures (September 2014) and Hunedoara (December 2014), • Consolidated cash position at year end (including restricted bank for €3.5 million and €1.2 million respectively, consistent with Profi t (loss) after tax the assets’ last reported book values. deposits, short term deposits and held for trading fi nancial assets) Consolidated cash position* of €41.7 million (31 December 2012: €33.7 million) and current • Improved occupancy and turnover were recorded across the 2014: €(120) million cash position of circa €39.5 million (€7 million restricted). Company’s existing shopping and entertainment centers in 2014: €41.7 million 2013: €(218) million the CEE, with the overall portfolio occupancy level increasing 2013: €33.7 million €m 300 €m 250 • Gearing increased to 74% (31 December 2013: 64%) as a result of to 94% as of 31 December 2014. 270 impairment losses and fi nance costs incurred during the year. - At Torun Plaza, Poland, occupancy increased to 92.5% 240 200 (2013: 89%). An additional 4,100 sqm of GLA was opened 210 Key highlights since the period end during the year, and asset management initiatives contributed 180 150 to a 21.2% increase in turnover and 6.3% increase in footfall 150 • On 24 February 2015, the Israeli credit rating agency which is a compared to 2013.
Recommended publications
  • Elbit Medical Technologies Initiation of Coverage
    Elbit Medical Technologies Initiation of coverage Two promising private assets Pharma & biotech 28 June 2018 Elbit Medical Technologies is an Israel-based healthcare investment company traded on the TASE. It is invested in two private companies: Price* NIS1.12 InSightec is a commercial-stage medical device company marketing a non- Market cap NIS259m invasive thermal tissue ablation therapy in three indications and Gamida *Priced as at 26 June 2018 Cell is a cell and immune therapy company developing a universal bone NIS3.64/US$ marrow transplant (BMT) product for haematological malignancies. Net debt ($m) at 31 December 2017 42.4 Although their recent offerings of NIS182m of convertible notes lengthen Shares in issue 231.4m the cash runway it raises the prospect of dilution in 2022. In addition, the Free float 10.8% parent company Elbit Imaging (~89% owned) has its own challenges. We value Elbit Medical at NIS407m or NIS1.76 per share. Code EMTC Primary exchange TASE Revenue PBT* EPS* DPS P/E Yield Secondary exchange N/A Year end ($m) ($m) ($) ($) (x) (%) 12/15 1.8 (1.1) 0.0 0.0 N/A N/A Share price performance 12/16 0.0 (3.7) 0.0 0.0 N/A N/A 12/17 0.0 (5.2) 0.0 0.0 N/A N/A Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments. InSightec: A non-invasive operating room Elbit Medical currently holds a ~22% (~19% fully diluted) stake in InSightec, a commercial-stage medical device company.
    [Show full text]
  • NASDAQ Stock Market
    Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85
    [Show full text]
  • Alphabetical Listing by Company Name
    FOREIGN COMPANIES REGISTERED AND REPORTING WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION December 31, 2015 Alphabetical Listing by Company Name COMPANY COUNTRY MARKET 21 Vianet Group Inc. Cayman Islands Global Market 37 Capital Inc. Canada OTC 500.com Ltd. Cayman Islands NYSE 51Job, Inc. Cayman Islands Global Market 58.com Inc. Cayman Islands NYSE ABB Ltd. Switzerland NYSE Abbey National Treasury Services plc United Kingdom NYSE - Debt Abengoa S.A. Spain Global Market Abengoa Yield Ltd. United Kingdom Global Market Acasti Pharma Inc. Canada Capital Market Acorn International, Inc. Cayman Islands NYSE Actions Semiconductor Co. Ltd. Cayman Islands Global Market Adaptimmune Ltd. United Kingdom Global Market Adecoagro S.A. Luxembourg NYSE Adira Energy Ltd. Canada OTC Advanced Accelerator Applications SA France Global Market Advanced Semiconductor Engineering, Inc. Taiwan NYSE Advantage Oil & Gas Ltd. Canada NYSE Advantest Corp. Japan NYSE Aegean Marine Petroleum Network Inc. Marshall Islands NYSE AEGON N.V. Netherlands NYSE AerCap Holdings N.V. Netherlands NYSE Aeterna Zentaris Inc. Canada Capital Market Affimed N.V. Netherlands Global Market Agave Silver Corp. Canada OTC Agnico Eagle Mines Ltd. Canada NYSE Agria Corp. Cayman Islands NYSE Agrium Inc. Canada NYSE AirMedia Group Inc. Cayman Islands Global Market Aixtron SE Germany Global Market Alamos Gold Inc. Canada NYSE Alcatel-Lucent France NYSE Alcobra Ltd. Israel Global Market Alexandra Capital Corp. Canada OTC Alexco Resource Corp. Canada NYSE MKT Algae Dynamics Corp. Canada OTC Algonquin Power & Utilities Corp. Canada OTC Alianza Minerals Ltd. Canada OTC Alibaba Group Holding Ltd. Cayman Islands NYSE Allot Communications Ltd. Israel Global Market Almaden Minerals Ltd.
    [Show full text]
  • Geographic Listing by Country of Incorporation
    FOREIGN COMPANIES REGISTERED AND REPORTING WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION December 31, 2010 Geographic Listing by Country of Incorporation COMPANY COUNTRY MARKET Antigua Sinovac Biotech Ltd. Antigua Global Mkt Argentina Alto Palermo S.A. Argentina Global Mkt Banco Macro S.A. Argentina NYSE BBVA Banco Frances S.A. Argentina NYSE Cresud Sacif Argentina Global Mkt Empresa Distribuidora y Comercializadora Norte S.A. - Edenor Argentina NYSE Grupo Financiero Galicia S.A. Argentina Global Mkt IRSA Inversiones y Representacions, S.A. Argentina NYSE MetroGas S.A. Argentina OTC Nortel Inversora S.A. Argentina NYSE Pampa Energia SA Argentina NYSE Petrobras Argentina S.A. Argentina NYSE Telecom Argentina S.A. Argentina NYSE Transportadora de Gas del Sur S.A. Argentina NYSE YPF S.A. Argentina NYSE Australia Allied Gold Ltd. Australia OTC Alumina Ltd. Australia NYSE BHP Billiton Ltd. Australia NYSE Genetic Technologies Ltd. Australia Global Mkt Metal Storm Ltd. Australia OTC Novogen Ltd. Australia Global Mkt Orbital Corp Ltd. Australia OTC Prana Biotechnology Ltd. Australia Cap. Mkt Progen Pharmaceuticals Ltd. Australia OTC Rio Tinto Ltd. Australia OTC Samson Oil & Gas Ltd. Australia NYSE-Amex Sims Metal Management Ltd. Australia NYSE Westpac Banking Corp. Australia NYSE Bahamas Calpetro Tankers (Bahamas I) Ltd. Bahamas OTC - Debt Calpetro Tankers (Bahamas II) Ltd. Bahamas OTC - Debt Calpetro Tankers (Bahamas III) Ltd. Bahamas OTC - Debt Ultrapetrol (Bahamas) Ltd. Bahamas Global Mkt Belgium Anheuser-Busch Inbev SA/NV Belgium NYSE Etablissements Delhaize Freres & Cie - Le Lion Belgium NYSE Page 1 COMPANY COUNTRY MARKET Bermuda AllShips Ltd. Bermuda OTC Alpha and Omega Semiconductor Ltd. Bermuda Global Mkt Asia Pacific Wire & Cable Corp.
    [Show full text]
  • 2/26/2010 Root-Suffix Affected NASDAQ-Listed Symbols.Xlsx Current Symbol Security Name AMSWA American Software, Inc. Class A
    2/26/2010 Root-Suffix Affected NASDAQ-Listed Symbols.xlsx Current Symbol Security Name AMSWA American Software, Inc. Class A Common Stock AMTCP Ameritrans Capital Corporation 9.375% Participating Preferred Stock APAGF Apco Oil and Gas International Inc. Ordinary Shares APCVZ Fresenius Kabi Pharmaceuticals Holding, Inc. Contingent Value Rights ARDNA Arden Group, Inc. Class A Common Stock ARTNA Artesian Resources Corporation Class A Common Stock ASCMA Ascent Media Corporation Series A Common Stock ASRVP AmeriServ Financial Inc. AmeriServ Financial Trust I - 8.45% Beneficial Unsecured Securities, Series A ASTIZ Ascent Solar Technologies, Inc. Class B Warrants ASURD Asure Software, Inc Common Stock AUTCU AutoChina International Limited Unit AUTCW AutoChina International Limited Warrant BANFP BancFirst Corporation - BFC Capital Trust II Cumulative Trust Preferred Securities BELFA Bel Fuse Inc. Class A Common Stock BELFB Bel Fuse Inc. Class B Common Stock BLDRR Builders FirstSource, Inc. transferable subscription rights BNHNA Benihana Inc. Class A Common Stock BPOPM Popular, Inc. Popular Capital Trust II - 6.125% Cumulative Monthly Income Trust Preferred Securities BPOPN Popular, Inc. 6.70% Cumulative Monthly Income Trust Preferred Securities BWINA Baldwin & Lyons, Inc. Class A Common Stock BWINB Baldwin & Lyons, Inc. Class B Common Stock CABLU China Cablecom Holdings, Ltd. Units (British Virgin Islands) CABLW China Cablecom Holdings, Ltd. Warrants 4/10/2010 (British Virgin Islands) CALPW Caliper Life Sciences Inc Warrant CBMXW CombiMatrix Corporation Warrants CCPCN Capital Crossing Preferred Corporation Series D Non-Cumulative Exchangeable Preferred Stock CENTA Central Garden & Pet Company Class A Common Stock Nonvoting CHINA CDC Corporation Class A Common Shares CHOPU China Gerui Advanced Materials Group Limited Units 1 Sh & 2 Wts (Virgin Islands British) CHOPW China Gerui Advanced Materials Group Limited Warrant 03/19/2011 (Virgin Islands British) CHSCP CHS Inc.
    [Show full text]
  • Board Changes
    9 July 2014 Plaza Centers N.V. (the “Company” or “Plaza”) Board Changes The directors of Plaza, a leading emerging markets property developer, today announces that, following its Annual General Meeting (“AGM”) held on 8 July 2014, the following Board appointments will take place with immediate effect: Mr. Ron Hadassi (executive director) (49) has a broad experience in leading real estate firms. Mr. Hadassi is currently the Chairman of Elbit Imaging Limited. In addition, Mr. Hadassi is a senior manager of Bronfman-Fisher Group, engaged in industry, real estate, finance and retail and holds various positions within the Bronfman-Fisher Group. Mr. Hadassi also currently holds directorships in the Bronfman-Fisher Group and in Nanette Real Estate Group N.V. Mr. Hadassi has a BA in Economics, Political Science from the Tel Aviv University, an LLB from the Tel Aviv University and an MBA from the Tel Aviv University. Mr. David Dekel (non-executive director) (49) is currently a non-executive director at Nanette Real Estate Group N.V., a residential developer operating in Central Europe. Mr. Dekel currently also holds directorships in Endeavour Enterprises N.V., Endeavour Holding B.V., Endeavour Investments SRL, Gilat Satellite Networks (Holland) B.V., Gilat to Home Latin America (Holland) B.V. and Circuitronix B.V. In the previous 5 years Mr. Dekel was a director of Blue Phoenix Solutions B.V. Mr. Dekel holds a BBA from the Delta University in Utrecht, the Netherlands and an MBA from the University of Teesside (the Hague extension) in The Hague, the Netherlands. Mr. Shlomi Kelsi (non-executive director) (42) is currently the managing director of all holding subsidiaries of Ampal- American Israel Corporation.
    [Show full text]
  • CERAGON NETWORKS LTD. (Exact Name of Registrant As Specified in Its Charter)
    As filed with the Securities and Exchange Commission on March 31, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report __________ Commission file number 0-30862 CERAGON NETWORKS LTD. (Exact Name of Registrant as Specified in Its Charter) Israel (Jurisdiction of Incorporation or Organization) 24 Raoul Wallenberg Street, Tel Aviv 69719, Israel (Address of Principal Executive Offices) Zvi Maayan (+972) 3-543-1643 (tel.), (+972) 3-543-1600 (fax), 24 Raoul Wallenberg Street, Tel Aviv 6971920, Israel (Name, Telephone, E-mail and/or Facsimile Number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Ordinary Shares, Par Value NIS 0.01 CRNT Nasdaq Global Select Market Securities registered or to be registered pursuant to Section 12(g) of the Act: None Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report 80,662,805 Ordinary Shares, NIS 0.01 par value.
    [Show full text]
  • Ticker Name Sector Subgroup Market Cap Price P/E Gryld ESLT ELBIT SYSTEMS LTD Aerospace/Defense Aerospace/Defense-Equip 1872732
    Ticker Name Sector Subgroup Market Cap Price P/E GrYld ESLT ELBIT SYSTEMS LTD Aerospace/Defense Aerospace/Defense-Equip 1872732000 43.72 10.16 3.29 TATT TAT TECHNOLOGIES LTD Aerospace/Defense Aerospace/Defense-Equip 44163170 5.01 N/A N/A DELTY DELTA GALIL INDUSTRIES-ADR Apparel Apparel Manufacturers 132338700 5.65 N/A 6.01 CGEN COMPUGEN LTD Biotechnology Medical-Biomedical/Gene 142664900 4.16 N/A N/A PNTR POINTER TELOCATION LTD Commercial Services Commercial Services 19191250 4.01 11.46 N/A LAXAF LAXAI PHARMA LTD Commercial Services Research&Development 570408.8 0.01 N/A N/A BPHX BLUEPHOENIX SOLUTIONS LTD Computers Computer Services 15623440 0.63 N/A N/A JCDA JACADA LTD Computers Computer Services 9037805 2.25 N/A N/A TISA TOP IMAGE SYSTEMS LTD Computers Computers-Integrated Sys 17851280 2.00 18.18 N/A ELTK ELTEK LTD Electronics Circuit Boards 6940612 1.05 N/A N/A ELRNF ELRON ELECTRONIC INDS LTD Electronics Electronic Compo-Misc 122792500 4.14 N/A N/A RADA RADA ELECTRONIC INDS LTD Electronics Electronic Compo-Misc 19954930 2.25 12.50 N/A ORBK ORBOTECH LTD Electronics Electronic Measur Instr 444145500 10.31 7.26 N/A CAMT CAMTEK LTD Electronics Electronic Measur Instr 56486220 1.98 6.83 N/A ITRN ITURAN LOCATION AND CONTROL Electronics Electronic Secur Devices 258956200 12.35 N/A 8.10 MAGS MAGAL SECURITY SYS LTD Electronics Electronic Secur Devices 37967580 2.40 N/A N/A OTIV ON TRACK INNOVATIONS LTD Electronics Identification Sys/Dev 45468330 1.46 N/A N/A BSI ALON HOLDINGS BLUE SQ-ADR Food Food-Retail 342303500 5.19 N/A N/A WILC G.
    [Show full text]
  • Small, Savvy, High-Tech Firms Preponderate Among Israeli Multinationals, Survey Finds
    Small, savvy, high-tech firms preponderate among Israeli multinationals, survey finds EMBARGO: The contents of this report must not be quoted or summarized in the print, broadcast or electronic media before September 2nd, 2009, 10:00 a.m. Israel; 7 a.m. GMT and 3:00 a.m. United States EST. Release of the second ranking of Israeli outward investors Jerusalem and New York , September 2nd, 2009 The second annual survey of Israeli multinational enterprises (MNEs) is being released today. It was conducted by a joint team composed of the Manufacturers Association of Israel, Tel Aviv University, Hebrew University and the Vale Columbia Center on Sustainable International Investment (VCC), a joint undertaking of Columbia Law School and The Earth Institute at Columbia University in New York.1 The survey is part of a long-term, multi-country study of the rapid global expansion of multinational enterprises (MNEs) from emerging markets. The results released today cover the year 2007, although some information on 2008 is also provided. In 2007, Israel's top 20 MNEs – ranked by foreign assets – had over USD 12 billion in foreign assets (table 1), over USD 26 billion in foreign sales (including exports), and employed nearly 68,000 persons abroad. Foreign assets, sales and employment had increased by 33%, 8% and 24%, respectively, since 2006 (table 2). Four firms, Israel Chemicals, Amdocs, Teva and Ormat, together accounted for 60% of the total foreign assets of the top 20. An important clarification is in order. The report speaks of ‘the top 20’ for convenience. It is not in fact possible to be certain that the 20 companies listed in table 1 below are the largest Israeli investors abroad.
    [Show full text]
  • London Session of the Russell Tribunal on Palestine 20Th to 22Nd November 2010 Expert's Presentations – INDEX
    London session of the Russell Tribunal on Palestine 20th to 22nd November 2010 Expert's presentations – INDEX Day One - Saturday 20th of November The Legal Framework relevant to corporate conduct Richard Hermer QC Yasmine Gado Dr William Bourdon Implications of corporate activities in and around settlements Dr Dalit Baum Hugh Lanning Wael Natheef Adri Nieuwhof Ghaleb Mashni John Dorman Trade and labelling of settlement goods Salma Karmy Christophe Perrin Nancy Kricorian and Rae Abileah Phon Van Den Biesen Genevieve Coudrais Day two - Sunday 21st of November Financial services sector Merav Amir Mario Franssen Saskia Muller The security industry and the war industry John Hilary Maria Lahood Josh Ruebner Merav Amir / Dr Dalit Baum Shir Hever and Jamal Juma'a Paul Troop Chris Osmond Ben Hayes 1 REDRESS FOR PALESTINIAN VICTIMS OF HUMAN RIGHTS ABUSES IN THE COURTS OF ENGLAND & WALES1 Richard Hermer QC - Doughty Street Chambers, London This paper would not have been possible without the input of Andrew Sanger of the University of Cambridge who provided the Tribunal with the first draft of this document based upon his careful and erudite researches. Although all errors are mine, he should be considered as co-author. 1. INTRODUCTION The Tribunal have asked me to consider whether, and if so how, English law could provide remedies to victims of human rights abuses by reference to a number of specific examples. Whilst I remain happy to talk to these examples at the hearing, I hope I can be forgiven for thinking that it is likely to be of greater assistance to the Tribunal if I provide an overview of the basic components of English law in so far as they relate to redress and accountability for victims of human rights abuses.
    [Show full text]
  • Bluestar Israel Global Index® (BIGI®): End-Q1 2015 Fact Sheet
    BlueStar Israel Global Index® (BIGI®): End-Q1 2015 Fact Sheet Index Overview The BlueStar Israel Global Index (’BIGI’) provides a benchmark for investors to track the broadest and deepest universe of Israeli public companies. The index is constructed using BlueStar Indexes’ unique methodology and proprietary database of Israeli and Israeli-linked companies. BIGI includes the largest and most liquid companies as well as mid and small cap companies that display sufficient liquidity for global investors. BIGI is calculated and maintained by Standard & Poor’s based on a methodology developed by BlueStar Indexes and the International Securities Exchange in consultation with Standard & Poor’s. The Index uses a modified capitalization-weighted methodology and is rigorously float-adjusted to exclude corporate cross holdings. Index components are reviewed semi-annually for eligibility, and the weights are reset according to that distribution. The BlueStar Israel Global Index has been created to provide investors with an investable product allowing them to quickly take advantage of both event-driven news and long-term economic trends as the economy and companies of Israel continue to evolve. Top Ten Index Constituents GICS Sector Exposure Index Weight Industry Weight Company (Mar. 31, 2015) Information Technology 33.6% Health Care 32.0% Teva Pharmaceutical 12.93% Financials 16.0% Perrigo Company 12.44% Energy 4.4% Check Point Software 6.42% Materials 3.8% Amdocs Ltd 5.25% Industrials 3.2% Bank Leumi 2.95% Telecommunications Services 2.5% Bank Hapoalim 2.84% Consumer Discretionary 1.6% VeriFone Systems 2.36% Consumer Staples 1.5% Verint Systems 2.34% Utilities 1.4% Nice Systems Ltd 2.16% BEZEQ Israeli Telecom.
    [Show full text]
  • Summarized English Version of the Original Document in Hebrew)
    December 3, 2012 Members of the Board Strauss Group Ltd. Dear Sirs, Re: Compensation information for the CEO position (Summarized English version of the original document in Hebrew) 1. Per your request, please find enclosed comparative information regarding compensation levels for the CEO position in companies with similar characteristics to Strauss Group. 2. Prof. Moshe Zviran Ltd. is the leading provider of information and consulting services for top executives' compensation and benefits practices in Israel. The Company serves a wide variety organizations including Teva, Bezeq, Israel Chemicals, Machteshim, Bank Hapoalim, Bank Discount, Tnuva, Clal Insurance, Migdal, Menorah, Tzur-Shamir, AIG, Cellcom, Pelephone, Partner Communications, Hot, Azrieli, Shikun Binui, El-Al, Elbit Imaging, Nisko, Avgol, Space Communications, Nice Systems, Verint, Click Software, Ophir Optronics, Nova, Stratasys, Gilat Satellite, Gamida Cell, Eposnse, Evogene, VBL, Compugen, and many other companies. Methodology 3. To provide comparable information and ensure validity and accuracy of this analysis, we use rigorous methodologies to ensure that the surveyed position is carefully matched according to revenues scope and responsibilities. 4. The comparative data for the requested positions were extracted from our live, up-to-date, information database of senior management at over 350 companies. Our database is considered as the most comprehensive in Israel and has become the industry standard for negotiating remuneration levels for Israeli top executives. 5. The comparator group consists of 10 companies with revenues above 1 billion USD, including: Osem, Tnuva, El-Al, Hot, Machteshim, Cellcom, Partner, Pelephone, Shufersal, Shikun&Binui. Some of the companies are publicly-traded while others are privately-owned; some have global operations (such as Machteshim and Shikun&Binui) while others operate only in Israel.
    [Show full text]